Total Impact of Cannabis Market Projected to Reach $48 Billion in 2019

The cannabis markets are growing like a weed in both the U.S. and global markets. Each projection seems to raise the ceiling even higher than before. A recent article in the Marijuana Business Daily projected that: “Total economic impact of the cannabis industry will range from $39.2 billion to $48 billion in 2019 – about a 35% increase over 2018 and the U.S. cannabis sales in 2018 were between $8.6 billion and $10.8 billion – more than U.S. spending on e-cigarettes, the video game Fortnite and Goldfish crackers and U.S. sales of cannabis in 2019 will be about 35% higher than 2018 and could reach $30 billion by 2023. But are not just the industry giants that have green fields in front of them. Local dispensaries and recreational shops are a big part of the revenue tsunami. Another industry website laid forth the following industry picture and accompanying statistics: “As more states approve cannabis for use, an entirely new market has cropped up in the United States. Medical dispensaries, as well as recreational shops, are opening to supply marijuana to a broad base of consumers.” Active Companies from around the market with current developments this week include: Marijuana Company of America, Inc. (OTCQB: MCOA), Hemp Inc. (OTCPK: HEMP), Medical Marijuana, Inc. (OTCPK: MJNA), Sipp Industries, Inc. (OTCPK: SIPC), Smart Cannabis Corp. (OTCPK: SCNA).

Marijuana Company of America Issues 2019 Shareholder Letter

via NetworkWire – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTCQB: MCOA), an innovative hemp and cannabis corporation, today announces that on May 1, 2019, the Company mailed a letter to its shareholders to update them on recent developments and new business opportunities. In the letter, the Company provided a discussion on its two current acquisitions underway a review of its recent financial and operating performance and details of its new Viva Buds(TM) brand that will serve as a manufacturing, distribution and retail delivery service for cannabis products in the state of California.

MassRoots Releases Update on Planned Acquisition of COWA Science Corporation

MassRoots, Inc. (“MassRoots” or the “Company”) (OTCQB:MSRT), a technology platform for the regulated cannabis industry, is pleased to release the following update on its planned acquisition of COWA Science Corporation (“COWA”) in a stock-based transaction valued at approximately $5.78 million, dependent upon COWA achieving revenue milestones of $2.5 and $7.5 million (the “Planned Acquisition”). For more information on the Planned Acquisition, please see the Company’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on February 12, 2019.
Stock Symbols

String of Legal Victories Puts CBD and Cannabis into International Spotlights

Over the past couple of years, cannabis has become a major topic in many countries’ agendas due to its therapeutic benefits. Regulators worldwide are now exploring opportunities within the cannabis market as it can be used as an alternative to certain traditional medical treatments. In particular, the U.S. marketplace is expected to be one of the most explosive markets. Despite cannabis still being federally illegal within the U.S., certain states, such as California and Colorado, which have legalized recreational cannabis contribute billions of dollars in revenue annually. Moreover, cannabidiol or CBD-based products have become increasingly common across the U.S. In late 2018, U.S. President Donald Trump signed the U.S. Farm Bill into effect, allowing the production of hemp. Shortly after, convenience stores and pharmacies began carrying hemp-derived CBD products. Even major pharmaceutical chains have begun to carry CBD products, promoting their healthcare benefits such as treating medical conditions and pain relieving properties. The U.S. Food and Drug Administration also approved the first cannabis-derived drug, Epidiolex, which is already being used to treat epilepsy in children. Overall, the combination of all of these recent events has exponentially accelerated the CBD marketplace. Moving forward, the CBD market is expected to continually grow as more countries began to adopt cannabis legalizations. According to data compiled by Brightfield Group, the U.S. CBD market is expected to reach USD 22 Billion by 2022. SinglePoint Inc. (OTC: SING), PotNetwork Holdings, Inc. (OTC: POTN), MassRoots, Inc. (OTC: MSRT) mCig, Inc. (OTC: MCIG), Medical Marijuana, Inc. (OTC: MJNA)

Isaac Dietrich, Chief Executive Officer of MassRoots, Inc., Discusses COWA Science Corporation Acquisition and Other Recent Events in an Exclusive New Audio Interview at SmallCapVoice.com, Inc.

SmallCapVoice.com, Inc. and MassRoots, Inc. (“MassRoots” or the “Company”) (OTC.QB: MSRT), a leading technology platform for the regulated cannabis industry, announced today that the Company is featured in a new audio interview at SmallCapVoice.com, Inc.
Stock Symbols

Big Box Retailers Rushing to add CBD Product Lines now

Over the previous few years, CBD has slowly grown in both consumer awareness and acceptance… but it has hit a point where there’s no going back and the momentum has retailers of all stripes wanting to get their own seat at the table. A February 2019 article on the CNN Business site, titled “America’s stores are taking the leap into cannabis products” commented on this surge: “Retailers are racing to grab a piece of the booming CBD market. Stores like DSW, Neiman Marcus, and Barney’s all recently began selling beauty products that feature (CBD). Barney’s upped the stakes (recently) when it revealed plans for a small, cannabis-themed shop at its Beverly Hills store that showcases CBD beauty products, along with glass pipes, gold rolling papers, and grinder necklaces. “There is a demand for high-end CBD products,” Kim D’Angelo, Neiman Marcus’ beauty buyer, told CNN Business. “CBD products are the next big thing in beauty.” The moves by these companies are a clear signal that CBD, the non-psychoactive cousin of THC, is hitting retail’s mainstream. The industry is expected to grow to $22 billion over the next three years, according to cannabis research firm Brightfield Group. The market for hemp-based CBD products reached $619 million in the United States (in 2018), Brightfield estimated. But changing consumer attitudes will drive up sales in the coming years, analysts say. Active Companies from around the market with current developments this week include: Marijuana Company of America, Inc. (OTC:MCOA), Kona Gold Solutions, Inc. (OTC: KGKG), Terra Tech Corp. (OTC: TRTC), PotNetwork Holdings, Inc (OTC: POTN), Liberty Health Sciences Inc. (CSE: LHS) (OTC: LHSIF).

Marijuana Company of America Enters Strategic Partnership With MassRoots to Promote the hempSMART CBD Product Line

via NetworkWire – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC: MCOA), an innovative hemp and cannabis corporation, is pleased to announce that the Company’s wholly owned subsidiary hempSMART(TM) has entered into a strategic marketing agreement with MassRoots, Inc. (OTCQB: MSRT) to promote its hemp CBD formulated product line.

MassRoots Adds Robert Hymers to Its Strategic Advisory Board

MassRoots, Inc. (“MassRoots” or the “Company”) (OTCQB: MSRT), a leading technology platform for the regulated cannabis industry, is pleased to announce it has added cannabis industry veteran Mr. Robert L. Hymers to its Strategic Advisory Board. In this capacity, Mr. Hymers is expected to help guide MassRoots’ strategic investments and partnerships in the rapidly growing cannabis industry.